Barry Gertz
Private Equity Investor at BLACKSTONE INC.
Profile
Barry J.
Gertz currently works at Cytel, Inc., as Director, Blackstone, Inc., as Managing Director from 2019, and Twin Bridges Life Sciences LLC, as Consultant in Drug Development from 2014.
Dr. Gertz also formerly worked at Cytel, Inc., as Director, Sesen Bio, Inc., as Independent Director, Merck & Co., Inc., as Senior VP& Head-Global Clinical Development from 1986 to 2014, HealthCare Ventures LLC, as Member of Scientific Advisory Board from 2010 to 2013, and Clarus Ventures LLC, as Venture Partner from 2014 to 2018.
Dr. Gertz received his undergraduate degree and doctorate degree from the University of Pennsylvania and doctorate degree from Perelman School of Medicine.
Barry Gertz active positions
| Companies | Position | Start |
|---|---|---|
| BLACKSTONE INC. | Private Equity Investor | 2018-12-31 |
| Twin Bridges Life Sciences LLC | Consultant / Advisor | 2014-01-06 |
Cytel, Inc.
 Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of Barry Gertz
| Companies | Position | End |
|---|---|---|
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 2018-01-11 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2014-06-30 |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | 2012-12-31 |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Barry Gertz
| University of Pennsylvania | Doctorate Degree |
| Perelman School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BLACKSTONE INC. | Finance |
| Private companies | 5 |
|---|---|
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Technology Services |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| Twin Bridges Life Sciences LLC |
- Stock Market
- Insiders
- Barry Gertz